TaiMed Biologics receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
TaiMed Biologics (4147)
TaiMed Biologics stock price live, this page displays TWO 4147 stock exchange data. View the 4147 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the TaiMed Biologics real time stock price chart below.
What Is the TaiMed Biologics Stock Price Today?
The TaiMed Biologics stock price today is 77.40.
What Is the Stock Symbol for TaiMed Biologics?
The stock symbol for TaiMed Biologics is ""4147.""
What Stock Exchange Does TaiMed Biologics Trade On?
TaiMed Biologics is listed and trades on the TPEX stock exchange.
Is TaiMed Biologics a Good Stock to Buy?
Determining whether TaiMed Biologics—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4147 quote. (ISIN: TW0004147004)
What Is the TaiMed Biologics Stock Price Today?
The TaiMed Biologics stock price today is 77.40.
What Is the Stock Symbol for TaiMed Biologics?
The stock symbol for TaiMed Biologics is ""4147.""
What Stock Exchange Does TaiMed Biologics Trade On?
TaiMed Biologics is listed and trades on the TPEX stock exchange.
Is TaiMed Biologics a Good Stock to Buy?
Determining whether TaiMed Biologics—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4147 quote. (ISIN: TW0004147004)
TPEX
Currency in TWD
77.40
-1.40(-1.78%)
Closed·
Fair Value
An estimate of a TaiMed Biologics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
76.00
78.80
52 wk Range
65.90
108.50
4147 Scorecard
Full Analysis
RSI suggests the stock is in oversold territory
Unusual trading volume
1/2
Fair Value
An estimate of a TaiMed Biologics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
76.0078.80
52 wk Range
65.90108.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4147 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a TaiMed Biologics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
161.00
Upside
+108.01%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Biotechnology industry
- TaiMed Biologics receives Investment Bank Analyst Rating Update
- Investing.com
Pro - TaiMed Biologics receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- TaiMed Biologics receives Investment Bank Analyst Rating Update
- Investing.com
Pro - TaiMed Biologics receives Investment Bank Analyst Rating Update
- Investing.com
Pro - TaiMed Biologics receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
TaiMed Biologics Company Profile
TaiMed Biologics Inc., a biotechnology company, develops, manufactures, and commercializes drugs for the treatment and prevention of infectious diseases. It develops and markets Trogarzo IV infusion and Trogarzo IV push, a monoclonal antibody for HIV treatment. The company is also developing TMB-365, a monoclonal antibody used for HIV treatment and prevention which has completed a phase-1 clinical trial; and TMB-365 and TMB-380 combination, a monoclonal antibody combination therapy for HIV that is in phase-1b/2a clinical trial, as well as antibody-drug conjugates, for cancer treatment. In addition, it offers contract development and manufacturing services. The company has a research and development agreement for Trogarzo TMB-355 with Genentech and Biogen Inc., and authorizes Samsung Biologics to produce TMB-355. TaiMed Biologics Inc. was incorporated in 2007 and is headquartered in Taipei City, Taiwan.
Compare 4147 to Peers and Sector
Metrics to compare | 4147 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4147PeersSector | |
|---|---|---|---|---|
P/E Ratio | −101.7x | −17.3x | −0.5x | |
PEG Ratio | 2.00 | 0.02 | 0.00 | |
Price/Book | 5.4x | 2.9x | 2.6x | |
Price / LTM Sales | 35.4x | 28.1x | 3.3x | |
Upside (Analyst Target) | 104.3% | 0.0% | 42.9% | |
Fair Value Upside | Unlock | −11.2% | 6.2% | Unlock |
Analyst Ratings
2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 161.00
(+108.01% Upside)
Earnings
Latest Release
Aug 07, 2025
EPS / Forecast
-- / -0.05
Revenue / Forecast
-- / 183.00M
FAQ
What Stock Exchange Does TaiMed Biologics Trade On?
TaiMed Biologics is listed and trades on the Taipei Exchange stock exchange.
What Is the Stock Symbol for TaiMed Biologics?
The stock symbol for TaiMed Biologics is "4147."
What Is the TaiMed Biologics Market Cap?
As of today, TaiMed Biologics market cap is 21.52B.
What Is TaiMed Biologics's Earnings Per Share (TTM)?
The TaiMed Biologics EPS (TTM) is -0.77.
When Is the Next TaiMed Biologics Earnings Date?
TaiMed Biologics will release its next earnings report on 11 Nov 2025.
From a Technical Analysis Perspective, Is 4147 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has TaiMed Biologics Stock Split?
TaiMed Biologics has split 1 times.
How Many Employees Does TaiMed Biologics Have?
TaiMed Biologics has 0 employees.
What is the current trading status of TaiMed Biologics (4147)?
As of 12 Aug 2025, TaiMed Biologics (4147) is trading at a price of 77.40, with a previous close of 88.00. The stock has fluctuated within a day range of 76.00 to 78.80, while its 52-week range spans from 65.90 to 108.50.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.